z-logo
Premium
P2–155: Development of sensitive and specific ELISAs for three–repeat and four–repeat tau isoforms
Author(s) -
Luk Connie Y.,
Giovani Gavin,
Lees Andrew J.,
Silva Rohan
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.993
Subject(s) - gene isoform , polyclonal antibodies , tau protein , monoclonal antibody , antibody , recombinant dna , epitope , microbiology and biotechnology , peptide , chemistry , biomarker , antigen , biology , biochemistry , alzheimer's disease , immunology , medicine , disease , gene
increased levels of 27OHC. Among patients with different CNS diseases, most had an increased level of at least one of the two oxysterols. Results: In CSF from 18 AD and 20 MCI patients the levels of 24and 27OHC were significantly increased and 24OHC was significantly positively correlated with T-tau (r 0.55, P 65 ng/L) and A 42 ( 500 ng/L) were set according with literature. In case of AD, the percentage of patients with increased levels of 24OHC, T-tau, P-tau and decreased A 42 were similar (ranging from 55 to 67%). In case of MCI, 50% of the patients had increased CSF levels of 24OHC, whereas only 18% and 24% of this population had increased levels of T-tau and P-tau. The high fraction of MCI patients with increased CSF 24OHC (50%), compared with the smaller number of the same patients with a significant alteration of the levels of the other markers, is consistent with the possibility that 24OHC is a new biomarker with a high negative predictive value in connection with evaluation of patients with cognitive impairment disease.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here